The FDA announced on 2026-10-01 that Zydus Pharmaceuticals (USA) Inc is recalling Hydrocortisone Sodium Succinate for Injection due to failed impurity specifications. The voluntary Class II recall affects 70,776 vials distributed nationwide.
How to tell if you have it
- Hydrocortisone Sodium Succinate Injection
- 100 mg/vial
- NDC 70710-1907-1
- Lot #: LB00047A, LB00048A
- Exp. Date 03/2028
The hazard
The recall is due to failed impurities and degradation specifications for the drug product.
Context
GovInfoNow's records show Zydus Pharmaceuticals (USA) Inc has 54 other recalls on record since 2012-03-14. Recent brand recalls include a 2026-08-05 recall of Zydus Mirabegron 25mg Tablets for N-Nitroso impurity risk, a 2026-04-29 recall of Zydus Erythromycin Tablets for N-Nitroso-Desmethyl-Erythromycin risk, and a 2026-03-09 recall of Icosapent Ethyl Capsules due to defects. Other recent recalls of similar products include QuVa Pharma's 2026-06-24 Methohexital Sodium recall for impurity failures, Sagent's 2026-05-04 Busulfan Injection recall for failed impurities risk, and OneSource Specialty Pharma's 2026-06-07 Methohexital Sodium recall for impurities risk.